APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Genomics Products

Compare research editions
View pricing & licenses

Selected research

Industry Research

Genomics Products Industry Research Report 2026

Report ID 17390729058 January 2026148 pages

Choose your research edition.

Industry ResearchGenomics Products Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Genomics Products Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Genomics Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genomics Products Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Genomics Products Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Genomics Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Genomics Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Genomics Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Genomics Products include Zymo Research, Active Motif, Thermo Fisher Scientific, Cayman Chemical, Diagenode, Abcam, New England Biolabs, Merck & Co. and Qiagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Genomics Products market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Genomics Products Market by Company

Zymo Research

Active Motif

Thermo Fisher Scientific

Cayman Chemical

Diagenode

Abcam

New England Biolabs

Merck & Co.

Qiagen

Bio-Rad

Illumina

Agilent

Perkinelmer

Epizyme Inc.

CellCentric Ltd.

ValiRx plc

EpiGentek

Syndax Pharmaceuticals

Spectrum Pharmaceuticals

Promega

Novartis

Genomics Products Segment by Type

Reagents and Consumables

Bioinformatics and Software

Instruments and Systems

Others

Genomics Products Segment by Application

Pharmaceutical & Biotechnological

Companies Academic & Research Institutes Contract

Research Organizations

Others

Genomics Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genomics Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Genomics Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Genomics Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Genomics Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Genomics Products Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Genomics Products Sales (k units) of Manufacturers (2021-2026) Table 7. Global Genomics Products Sales Market Share by Manufacturers (2021-2026) Table 8. Global Genomics Products Revenue of Manufacturers (2021-2026) Table 9. Global Genomics Products Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Genomics Products Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Genomics Products Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Genomics Products, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Genomics Products, Product Type & Application Table 14. Global Genomics Products Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Genomics Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zymo Research Company Information Table 19. Zymo Research Business Overview Table 20. Zymo Research Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Zymo Research Genomics Products Product Portfolio Table 22. Zymo Research Recent Developments Table 23. Active Motif Company Information Table 24. Active Motif Business Overview Table 25. Active Motif Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Active Motif Genomics Products Product Portfolio Table 27. Active Motif Recent Developments Table 28. Thermo Fisher Scientific Company Information Table 29. Thermo Fisher Scientific Business Overview Table 30. Thermo Fisher Scientific Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Thermo Fisher Scientific Genomics Products Product Portfolio Table 32. Thermo Fisher Scientific Recent Developments Table 33. Cayman Chemical Company Information Table 34. Cayman Chemical Business Overview Table 35. Cayman Chemical Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Cayman Chemical Genomics Products Product Portfolio Table 37. Cayman Chemical Recent Developments Table 38. Diagenode Company Information Table 39. Diagenode Business Overview Table 40. Diagenode Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Diagenode Genomics Products Product Portfolio Table 42. Diagenode Recent Developments Table 43. Abcam Company Information Table 44. Abcam Business Overview Table 45. Abcam Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Abcam Genomics Products Product Portfolio Table 47. Abcam Recent Developments Table 48. New England Biolabs Company Information Table 49. New England Biolabs Business Overview Table 50. New England Biolabs Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. New England Biolabs Genomics Products Product Portfolio Table 52. New England Biolabs Recent Developments Table 53. Merck & Co. Company Information Table 54. Merck & Co. Business Overview Table 55. Merck & Co. Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Merck & Co. Genomics Products Product Portfolio Table 57. Merck & Co. Recent Developments Table 58. Qiagen Company Information Table 59. Qiagen Business Overview Table 60. Qiagen Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Qiagen Genomics Products Product Portfolio Table 62. Qiagen Recent Developments Table 63. Bio-Rad Company Information Table 64. Bio-Rad Business Overview Table 65. Bio-Rad Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Bio-Rad Genomics Products Product Portfolio Table 67. Bio-Rad Recent Developments Table 68. Illumina Company Information Table 69. Illumina Business Overview Table 70. Illumina Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Illumina Genomics Products Product Portfolio Table 72. Illumina Recent Developments Table 73. Agilent Company Information Table 74. Agilent Business Overview Table 75. Agilent Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Agilent Genomics Products Product Portfolio Table 77. Agilent Recent Developments Table 78. Perkinelmer Company Information Table 79. Perkinelmer Business Overview Table 80. Perkinelmer Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Perkinelmer Genomics Products Product Portfolio Table 82. Perkinelmer Recent Developments Table 83. Epizyme Inc. Company Information Table 84. Epizyme Inc. Business Overview Table 85. Epizyme Inc. Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Epizyme Inc. Genomics Products Product Portfolio Table 87. Epizyme Inc. Recent Developments Table 88. CellCentric Ltd. Company Information Table 89. CellCentric Ltd. Business Overview Table 90. CellCentric Ltd. Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. CellCentric Ltd. Genomics Products Product Portfolio Table 92. CellCentric Ltd. Recent Developments Table 93. ValiRx plc Company Information Table 94. ValiRx plc Business Overview Table 95. ValiRx plc Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. ValiRx plc Genomics Products Product Portfolio Table 97. ValiRx plc Recent Developments Table 98. EpiGentek Company Information Table 99. EpiGentek Business Overview Table 100. EpiGentek Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. EpiGentek Genomics Products Product Portfolio Table 102. EpiGentek Recent Developments Table 103. Syndax Pharmaceuticals Company Information Table 104. Syndax Pharmaceuticals Business Overview Table 105. Syndax Pharmaceuticals Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Syndax Pharmaceuticals Genomics Products Product Portfolio Table 107. Syndax Pharmaceuticals Recent Developments Table 108. Spectrum Pharmaceuticals Company Information Table 109. Spectrum Pharmaceuticals Business Overview Table 110. Spectrum Pharmaceuticals Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Spectrum Pharmaceuticals Genomics Products Product Portfolio Table 112. Spectrum Pharmaceuticals Recent Developments Table 113. Promega Company Information Table 114. Promega Business Overview Table 115. Promega Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Promega Genomics Products Product Portfolio Table 117. Promega Recent Developments Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Genomics Products Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Novartis Genomics Products Product Portfolio Table 122. Novartis Recent Developments Table 123. Global Genomics Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Genomics Products Sales by Region (2021-2026) & (k units) Table 125. Global Genomics Products Sales Market Share by Region (2021-2026) Table 126. Global Genomics Products Sales by Region (2027-2032) & (k units) Table 127. Global Genomics Products Sales Market Share by Region (2027-2032) Table 128. Global Genomics Products Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Genomics Products Revenue Market Share by Region (2021-2026) Table 130. Global Genomics Products Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Genomics Products Revenue Market Share by Region (2027-2032) Table 132. North America Genomics Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Genomics Products Sales by Country (2021-2026) & (k units) Table 134. North America Genomics Products Sales by Country (2027-2032) & (k units) Table 135. North America Genomics Products Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Genomics Products Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Genomics Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Genomics Products Sales by Country (2021-2026) & (k units) Table 139. Europe Genomics Products Sales by Country (2027-2032) & (k units) Table 140. Europe Genomics Products Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Genomics Products Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Genomics Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Genomics Products Sales by Country (2021-2026) & (k units) Table 144. Asia Pacific Genomics Products Sales by Country (2027-2032) & (k units) Table 145. Asia Pacific Genomics Products Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Genomics Products Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Genomics Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Genomics Products Sales by Country (2021-2026) & (k units) Table 149. South America Genomics Products Sales by Country (2027-2032) & (k units) Table 150. South America Genomics Products Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Genomics Products Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Genomics Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Genomics Products Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Genomics Products Sales by Country (2027-2032) & (k units) Table 155. Middle East and Africa Genomics Products Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Genomics Products Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Genomics Products Sales by Type (2021-2026) & (k units) Table 158. Global Genomics Products Sales by Type (2027-2032) & (k units) Table 159. Global Genomics Products Sales Market Share by Type (2021-2026) Table 160. Global Genomics Products Sales Market Share by Type (2027-2032) Table 161. Global Genomics Products Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Genomics Products Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Genomics Products Revenue Market Share by Type (2021-2026) Table 164. Global Genomics Products Revenue Market Share by Type (2027-2032) Table 165. Global Genomics Products Price by Type (2021-2026) & (USD/unit) Table 166. Global Genomics Products Price by Type (2027-2032) & (USD/unit) Table 167. Global Genomics Products Sales by Application (2021-2026) & (k units) Table 168. Global Genomics Products Sales by Application (2027-2032) & (k units) Table 169. Global Genomics Products Sales Market Share by Application (2021-2026) Table 170. Global Genomics Products Sales Market Share by Application (2027-2032) Table 171. Global Genomics Products Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Genomics Products Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Genomics Products Revenue Market Share by Application (2021-2026) Table 174. Global Genomics Products Revenue Market Share by Application (2027-2032) Table 175. Global Genomics Products Price by Application (2021-2026) & (USD/unit) Table 176. Global Genomics Products Price by Application (2027-2032) & (USD/unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Genomics Products Distributors List Table 180. Genomics Products Customers List Table 181. Genomics Products Industry Trends Table 182. Genomics Products Industry Drivers Table 183. Genomics Products Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Genomics Products Product Image Figure 5. Global Genomics Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Genomics Products Market Size (2021-2032) & (US$ Million) Figure 7. Global Genomics Products Sales (2021-2032) & (k units) Figure 8. Global Genomics Products Average Price (USD/unit) & (2021-2032) Figure 9. Reagents and Consumables Product Image Figure 10. Bioinformatics and Software Product Image Figure 11. Instruments and Systems Product Image Figure 12. Others Product Image Figure 13. Pharmaceutical & Biotechnological Product Image Figure 14. Companies Academic & Research Institutes Contract Product Image Figure 15. Research Organizations Product Image Figure 16. Others Product Image Figure 17. Global Genomics Products Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Genomics Products, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Genomics Products Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Genomics Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Genomics Products Sales by Region in 2025 Figure 23. Global Genomics Products Revenue by Region in 2025 Figure 24. North America Genomics Products Market Size by Country in 2025 Figure 25. North America Genomics Products Sales Market Share by Country (2021-2032) Figure 26. North America Genomics Products Revenue Market Share by Country (2021-2032) Figure 27. United States Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Genomics Products Market Size by Country in 2025 Figure 31. Europe Genomics Products Sales Market Share by Country (2021-2032) Figure 32. Europe Genomics Products Revenue Market Share by Country (2021-2032) Figure 33. Germany Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Genomics Products Market Size by Country in 2025 Figure 44. Asia Pacific Genomics Products Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Genomics Products Revenue Market Share by Country (2021-2032) Figure 46. China Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Genomics Products Market Size by Country in 2025 Figure 55. South America Genomics Products Sales Market Share by Country (2021-2032) Figure 56. South America Genomics Products Revenue Market Share by Country (2021-2032) Figure 57. Brazil Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Genomics Products Market Size by Country in 2025 Figure 61. Middle East and Africa Genomics Products Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Genomics Products Revenue Market Share by Country (2021-2032) Figure 63. Egypt Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Genomics Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Genomics Products Sales Market Share by Type (2021-2032) Figure 69. Global Genomics Products Revenue Market Share by Type (2021-2032) Figure 70. Global Genomics Products Price (USD/unit) by Type (2021-2032) Figure 71. Global Genomics Products Sales Market Share by Application (2021-2032) Figure 72. Global Genomics Products Revenue Market Share by Application (2021-2032) Figure 73. Global Genomics Products Price (USD/unit) by Application (2021-2032) Figure 74. Genomics Products Value Chain Figure 75. Genomics Products Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Genomics Products Industry Opportunities and Challenges

Scope & coverage.

Types
  • Reagents and Consumables
  • Bioinformatics and Software
  • Instruments and Systems
  • Others
Applications
  • Pharmaceutical & Biotechnological
  • Companies Academic & Research Institutes Contract
  • Research Organizations
  • Others
Companies covered
  • Zymo Research
  • Active Motif
  • Thermo Fisher Scientific
  • Cayman Chemical
  • Diagenode
  • Abcam
  • New England Biolabs
  • Merck & Co.
  • Qiagen
  • Bio-Rad
  • Illumina
  • Agilent
  • Perkinelmer
  • Epizyme Inc.
  • CellCentric Ltd.
  • ValiRx plc
  • EpiGentek
  • Syndax Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Promega
  • Novartis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Genomics Products Market Size (2021-2032)
  4. 2.2.2 Global Genomics Products Sales (2021-2032)
  5. 2.2.3 Global Genomics Products Market Average Price (2021-2032)
  6. 2.3 Genomics Products by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Reagents and Consumables
  9. 2.3.3 Bioinformatics and Software
  10. 2.3.4 Instruments and Systems
  11. 2.3.5 Others
  12. 2.4 Genomics Products by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Pharmaceutical & Biotechnological
  15. 2.4.3 Companies Academic & Research Institutes Contract
  16. 2.4.4 Research Organizations
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Genomics Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Genomics Products Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Genomics Products Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Genomics Products Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Genomics Products Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Genomics Products, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Genomics Products, Product Type & Application
  8. 3.8 Global Manufacturers of Genomics Products, Established Date
  9. 3.9 Global Genomics Products Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zymo Research
  2. 4.1.1 Zymo Research Company Information
  3. 4.1.2 Zymo Research Business Overview
  4. 4.1.3 Zymo Research Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zymo Research Genomics Products Product Portfolio
  6. 4.1.5 Zymo Research Recent Developments
  7. 4.2 Active Motif
  8. 4.2.1 Active Motif Company Information
  9. 4.2.2 Active Motif Business Overview
  10. 4.2.3 Active Motif Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Active Motif Genomics Products Product Portfolio
  12. 4.2.5 Active Motif Recent Developments
  13. 4.3 Thermo Fisher Scientific
  14. 4.3.1 Thermo Fisher Scientific Company Information
  15. 4.3.2 Thermo Fisher Scientific Business Overview
  16. 4.3.3 Thermo Fisher Scientific Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Thermo Fisher Scientific Genomics Products Product Portfolio
  18. 4.3.5 Thermo Fisher Scientific Recent Developments
  19. 4.4 Cayman Chemical
  20. 4.4.1 Cayman Chemical Company Information
  21. 4.4.2 Cayman Chemical Business Overview
  22. 4.4.3 Cayman Chemical Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Cayman Chemical Genomics Products Product Portfolio
  24. 4.4.5 Cayman Chemical Recent Developments
  25. 4.5 Diagenode
  26. 4.5.1 Diagenode Company Information
  27. 4.5.2 Diagenode Business Overview
  28. 4.5.3 Diagenode Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Diagenode Genomics Products Product Portfolio
  30. 4.5.5 Diagenode Recent Developments
  31. 4.6 Abcam
  32. 4.6.1 Abcam Company Information
  33. 4.6.2 Abcam Business Overview
  34. 4.6.3 Abcam Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Abcam Genomics Products Product Portfolio
  36. 4.6.5 Abcam Recent Developments
  37. 4.7 New England Biolabs
  38. 4.7.1 New England Biolabs Company Information
  39. 4.7.2 New England Biolabs Business Overview
  40. 4.7.3 New England Biolabs Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 New England Biolabs Genomics Products Product Portfolio
  42. 4.7.5 New England Biolabs Recent Developments
  43. 4.8 Merck & Co.
  44. 4.8.1 Merck & Co. Company Information
  45. 4.8.2 Merck & Co. Business Overview
  46. 4.8.3 Merck & Co. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Merck & Co. Genomics Products Product Portfolio
  48. 4.8.5 Merck & Co. Recent Developments
  49. 4.9 Qiagen
  50. 4.9.1 Qiagen Company Information
  51. 4.9.2 Qiagen Business Overview
  52. 4.9.3 Qiagen Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Qiagen Genomics Products Product Portfolio
  54. 4.9.5 Qiagen Recent Developments
  55. 4.10 Bio-Rad
  56. 4.10.1 Bio-Rad Company Information
  57. 4.10.2 Bio-Rad Business Overview
  58. 4.10.3 Bio-Rad Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bio-Rad Genomics Products Product Portfolio
  60. 4.10.5 Bio-Rad Recent Developments
  61. 4.11 Illumina
  62. 4.11.1 Illumina Company Information
  63. 4.11.2 Illumina Business Overview
  64. 4.11.3 Illumina Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Illumina Genomics Products Product Portfolio
  66. 4.11.5 Illumina Recent Developments
  67. 4.12 Agilent
  68. 4.12.1 Agilent Company Information
  69. 4.12.2 Agilent Business Overview
  70. 4.12.3 Agilent Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Agilent Genomics Products Product Portfolio
  72. 4.12.5 Agilent Recent Developments
  73. 4.13 Perkinelmer
  74. 4.13.1 Perkinelmer Company Information
  75. 4.13.2 Perkinelmer Business Overview
  76. 4.13.3 Perkinelmer Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Perkinelmer Genomics Products Product Portfolio
  78. 4.13.5 Perkinelmer Recent Developments
  79. 4.14 Epizyme Inc.
  80. 4.14.1 Epizyme Inc. Company Information
  81. 4.14.2 Epizyme Inc. Business Overview
  82. 4.14.3 Epizyme Inc. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Epizyme Inc. Genomics Products Product Portfolio
  84. 4.14.5 Epizyme Inc. Recent Developments
  85. 4.15 CellCentric Ltd.
  86. 4.15.1 CellCentric Ltd. Company Information
  87. 4.15.2 CellCentric Ltd. Business Overview
  88. 4.15.3 CellCentric Ltd. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CellCentric Ltd. Genomics Products Product Portfolio
  90. 4.15.5 CellCentric Ltd. Recent Developments
  91. 4.16 ValiRx plc
  92. 4.16.1 ValiRx plc Company Information
  93. 4.16.2 ValiRx plc Business Overview
  94. 4.16.3 ValiRx plc Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 ValiRx plc Genomics Products Product Portfolio
  96. 4.16.5 ValiRx plc Recent Developments
  97. 4.17 EpiGentek
  98. 4.17.1 EpiGentek Company Information
  99. 4.17.2 EpiGentek Business Overview
  100. 4.17.3 EpiGentek Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 EpiGentek Genomics Products Product Portfolio
  102. 4.17.5 EpiGentek Recent Developments
  103. 4.18 Syndax Pharmaceuticals
  104. 4.18.1 Syndax Pharmaceuticals Company Information
  105. 4.18.2 Syndax Pharmaceuticals Business Overview
  106. 4.18.3 Syndax Pharmaceuticals Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Syndax Pharmaceuticals Genomics Products Product Portfolio
  108. 4.18.5 Syndax Pharmaceuticals Recent Developments
  109. 4.19 Spectrum Pharmaceuticals
  110. 4.19.1 Spectrum Pharmaceuticals Company Information
  111. 4.19.2 Spectrum Pharmaceuticals Business Overview
  112. 4.19.3 Spectrum Pharmaceuticals Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Spectrum Pharmaceuticals Genomics Products Product Portfolio
  114. 4.19.5 Spectrum Pharmaceuticals Recent Developments
  115. 4.20 Promega
  116. 4.20.1 Promega Company Information
  117. 4.20.2 Promega Business Overview
  118. 4.20.3 Promega Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Promega Genomics Products Product Portfolio
  120. 4.20.5 Promega Recent Developments
  121. 4.21 Novartis
  122. 4.21.1 Novartis Company Information
  123. 4.21.2 Novartis Business Overview
  124. 4.21.3 Novartis Genomics Products Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Novartis Genomics Products Product Portfolio
  126. 4.21.5 Novartis Recent Developments
5 Global Genomics Products Market Scenario by Region
  1. 5.1 Global Genomics Products Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Genomics Products Sales by Region: 2021-2032
  3. 5.2.1 Global Genomics Products Sales by Region: 2021-2026
  4. 5.2.2 Global Genomics Products Sales by Region: 2027-2032
  5. 5.3 Global Genomics Products Revenue by Region: 2021-2032
  6. 5.3.1 Global Genomics Products Revenue by Region: 2021-2026
  7. 5.3.2 Global Genomics Products Revenue by Region: 2027-2032
  8. 5.4 North America Genomics Products Market Facts & Figures by Country
  9. 5.4.1 North America Genomics Products Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Genomics Products Sales by Country (2021-2032)
  11. 5.4.3 North America Genomics Products Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Genomics Products Market Facts & Figures by Country
  16. 5.5.1 Europe Genomics Products Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Genomics Products Sales by Country (2021-2032)
  18. 5.5.3 Europe Genomics Products Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Genomics Products Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Genomics Products Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Genomics Products Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Genomics Products Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Genomics Products Market Facts & Figures by Country
  41. 5.7.1 South America Genomics Products Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Genomics Products Sales by Country (2021-2032)
  43. 5.7.3 South America Genomics Products Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Genomics Products Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Genomics Products Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Genomics Products Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Genomics Products Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Genomics Products Sales by Type (2021-2032)
  2. 6.1.1 Global Genomics Products Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Genomics Products Sales Market Share by Type (2021-2032)
  4. 6.2 Global Genomics Products Revenue by Type (2021-2032)
  5. 6.2.1 Global Genomics Products Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Genomics Products Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Genomics Products Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Genomics Products Sales by Application (2021-2032)
  2. 7.1.1 Global Genomics Products Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Genomics Products Sales Market Share by Application (2021-2032)
  4. 7.2 Global Genomics Products Revenue by Application (2021-2032)
  5. 7.2.1 Global Genomics Products Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Genomics Products Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Genomics Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Genomics Products Value Chain Analysis
  2. 8.1.1 Genomics Products Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Genomics Products Production Mode & Process
  5. 8.2 Genomics Products Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Genomics Products Distributors
  8. 8.2.3 Genomics Products Customers
9 Global Genomics Products Analyzing Market Dynamics
  1. 9.1 Genomics Products Industry Trends
  2. 9.2 Genomics Products Industry Drivers
  3. 9.3 Genomics Products Industry Opportunities and Challenges
  4. 9.4 Genomics Products Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst